Holders over time
- SGRY
- ELV
| Quarter | SGRY | ELV |
|---|---|---|
| Q3 2020 | 1 holders, $3.2m | 30 holders, $15.0bn |
| Q4 2020 | none listed holders, n.a. | 29 holders, $16.7bn |
| Q1 2021 | 1 holders, $271k | 25 holders, $18.6bn |
| Q2 2021 | 2 holders, $484m | 30 holders, $19.4bn |
| Q3 2021 | 3 holders, $14m | 26 holders, $18.5bn |
| Q4 2021 | 5 holders, $668m | 29 holders, $23.3bn |
| Q1 2022 | 5 holders, $778m | 31 holders, $23.9bn |
| Q2 2022 | 4 holders, $470m | 32 holders, $23.3bn |
| Q3 2022 | 3 holders, $67m | 34 holders, $22.6bn |
| Q4 2022 | 5 holders, $928m | 34 holders, $25.5bn |
| Q1 2023 | 6 holders, $1.2bn | 39 holders, $22.5bn |
| Q2 2023 | 6 holders, $1.5bn | 38 holders, $20.6bn |
| Q3 2023 | 6 holders, $958m | 34 holders, $19.8bn |
| Q4 2023 | 6 holders, $1.0bn | 36 holders, $20.3bn |
| Q1 2024 | 8 holders, $1.1bn | 35 holders, $21.3bn |
| Q2 2024 | 8 holders, $469m | 33 holders, $22.1bn |
| Q3 2024 | 8 holders, $1.1bn | 30 holders, $20.2bn |
| Q4 2024 | 7 holders, $428m | 32 holders, $15.9bn |
| Q1 2025 | 7 holders, $504m | 28 holders, $17.1bn |
| Q2 2025 | 6 holders, $380m | 27 holders, $14.8bn |
| Q3 2025 | 7 holders, $375m | 27 holders, $12.7bn |
| Q4 2025 | 5 holders, $316m | 25 holders, $17.0bn |
| Q1 2026 | 5 holders, $230m | 26 holders, $13.6bn |
| Q2 2026 | 4 holders, $311m | 28 holders, $17.7bn |
Surgery Partners Inc
- Holders
- 7
- Reported value
- $428m
- Buyers
- 4
- Sellers
- 1
Breadth +3 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 32
- Reported value
- $15.9bn
- Buyers
- 20
- Sellers
- 12
Breadth +8 among 94 comparable managers.
Who holds both, Q4 2024
Both (4)
First Eagle Investment Management LLC, Janus Henderson Group Ltd, Moore Capital Management LP, Wellington Management Group LLP
Only SGRY (3)
Freestone Grove Partners LP, Hudson Bay Capital Management LP, Point72 Asset Management LP
Only ELV (28)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Harris Associates LP, Invesco Ltd, Man Group PLC, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, and 3 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.